COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,510 Articles (22,870 medRxiv, 8,640 bioRxiv)

Most recent first Previous |  Page 468: Articles 4671-4680  | Next

Resolving a Guanine-Quadruplex Structure in the SARS-CoV-2 Genome through Circular Dichroism and Multiscale Molecular Modeling.
D'Anna, L., Miclot, T., Bignon, E., Perricone, U., Barone, G., Monari, A., Terenzi, A.
10.1101/2023.04.13.536758 — Posted: 2023-04-13
Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in patients with and without long COVID
Visvabharathy, L., Zhu, C., Orban, Z. S., Yarnoff, K., Palacio, N., Jimenez, M., Lim, P., Penaloza-MacMaster, P., Koralnik, I. J.
10.1101/2023.04.07.23288243 — Posted: 2023-04-12
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
Zhou, Z.-H., Cortese, M. M., Fang, J.-L., Wood, R., Hummell, D. S., Risma, K. A., Norton, A. E., KuKuruga, M., Kirshner, S., Rabin, R. L., Agarabi, C., Staat, M. A., Halasa, N., Ware, R., Stahl, A., McMahon, M., Browning, P., Maniatis, P., Bolcen, S., Edwards, K. M., Su, J. R., Dharmarajan, S., Forshee, R., Broder, K. R., Anderson, S., Kozlowski, S.
10.1101/2023.04.11.23288372 — Posted: 2023-04-12
The COVID-19 vaccination campaign in Switzerland and its impact on disease spread
Bekker-Nielsen Dunbar, M., Held, L.
10.1101/2023.04.06.23288251 — Posted: 2023-04-12
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
Brosh-Nissimov, T., Ma'aravi, N., Leshin-Carmel, D., Edel, Y., Ben Barouch, S., Segman, Y., Cahan, A., Barenboim, E.
10.1101/2023.04.07.23288144 — Posted: 2023-04-12
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease
Khatua, K., Alugubelli, Y. R., Yang, K., Reddy, V., Blankenship, L., Coleman, D., Atla, S., Chaki, S., Geng, Z., Ma, X., Xiao, J., Chen, P.-H., Cho, C.-C., Vatansever, E. C., Ma, Y., Yu, G., Neuman, B., Xu, S., Liu, W. R.
10.1101/2023.04.11.536467 — Posted: 2023-04-12
Analysis of SARS-CoV-2 Recombinant Lineages XBC and XBC.1 in the Philippines and Evidence for Delta-Omicron Co-infection as a Potential Origin
Pangilinan, E. A. R., Egana, J. M. C., Mantaring, R. J. Q., Telles, A. J. E., Tablizo, F. A., Lapid, C. M., Yangzon, M. S. L., Endozo, J. J. S., Padilla, K. S. A. R., Nipales, J. E., Carandang, L. C. D. L., Enriquez, Z. M. R., Barot, T. A. U., Manlimos, R. A., Mangonon, K. N. P., Plantig, M. E. L., Balucio, J. E. B., Lustria, J. M. B., Araiza, S. M. M., Llames, J.-H. S., Punayan, K. P., Serrano, R. P., Drueco, A. M., Lagnas, H. T., Bistayan, P. A., Aguilar, A. C., Charisse Apo, J. G., Austria, Y. V. D., Bustamante, N. F. M., Caelian, A. J. R., Fernandez, R. E., Galilea, X. A., Gamboa, M. M., Gervacio, C. J. A., Mollejon, Z. V., Pineda, J. P. N., Rico, K. B., Yap, J. M. C., Abad, M. C. S., Maralit, B. A., Ayes, M. E. C., Cutiongco-de la Paz, E. M., Saloma, C. P.
10.1101/2023.04.12.534029 — Posted: 2023-04-12
The Impact Of COVID-19 on Health Financing in Kenya
Kairu, A., Orangi, S., Mbuthia, B., Arwah, B., Guleid, F., Keru, J., Vilcu, I., Musuva, A., Ravishankar, N., Barasa, E.
10.1101/2023.04.05.23288177 — Posted: 2023-04-11
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged >=50 years in Ontario, Canada
Grewal, R., Buchan, S. A., Nguyen, L., Nasreen, S., Austin, P. C., Brown, K. A., Gubbay, J., Lee, N., Schwartz, K. L., Tadrous, M., Wilson, K., Wilson, S. E., Kwong, J. C., on behalf of the CIRN Provincial Collaborative Network investigators
10.1101/2023.04.11.23288403 — Posted: 2023-04-11
A methodological framework for assessing the benefit of SARS-CoV-2 vaccination following previous infection: case study of five to eleven year olds in the UK
Pagel, C., Wilde, H., Tomlinson, C., Mateen, B. A., Brown, K.
10.1101/2023.04.11.23288409 — Posted: 2023-04-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).